(2-(Piperidin-1-yl)pyridin-4-yl)methanamine dihydrochloride

Catalog No.: 
ACZLKT330
CAS No.: 
2703775-17-9
Molecular Formula: 
C11H19Cl2N3
Molecular Weight: 
264.20
(2-(Piperidin-1-yl)pyridin-4-yl)methanamine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$69.00InquiryInquiry
250mg95%$91.00InquiryInquiry
1g95%$164.00InquiryInquiry
5g95%$641.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-(Piperidin-1-yl)pyridin-4-yl)methanamine dihydrochloride
IUPAC Name(2-(piperidin-1-yl)pyridin-4-yl)methanamine dihydrochloride
Molecular FormulaC11H19Cl2N3
Molecular Weight264.20
SMILESNCC1=CC(N2CCCCC2)=NC=C1.[H]Cl.[H]Cl
InChI KeyATZXPHMZUSUGRH-UHFFFAOYSA-N
Synonym4-Pyridinemethanamine, 2-(1-piperidinyl)-, hydrochloride (1:2)
CAS No.2703775-17-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZLKT330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDWPR812 route compound structure diagram
    ACDWPR812144900-57-2In Stock
  4. Then
  5. ACZLKT330 route product structure diagram
    ACZLKT3302703775-17-9
Inquiry

2. ACZLKT330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZLKT330 route product structure diagram
    ACZLKT3302703775-17-9
Inquiry

3. ACZLKT330 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZLKT330 route product structure diagram
    ACZLKT3302703775-17-9
Inquiry

Comments (0)